Podiatrists in Royal Palm Beach, FL Accepting Medicare
5 Podiatrists found. Showing 1 - 5
 South Florida Foot & Ankle Centers Podiatrist Medicare: Medicare Enrolled Practice Location: 11412 Okeechobee Blvd, Royal Palm Beach, FL 33411 Phone: 561-793-6170 Fax: 561-795-3683 |
 Dr. Joshua Paul Daly, D.P.M, M.B.A Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 11412 Okeechobee Blvd, Royal Palm Beach, FL 33411 Phone: 561-793-6170 Fax: 561-795-3683 |
 Frankie Lynn Kirk, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 11412 Okeechobee Blvd, Royal Palm Beach, FL 33411 Phone: 561-793-6170 Fax: 561-795-3683 |
Dr. Jonathan M Cutler, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 11412 Okeechobee Blvd, Royal Palm Beach, FL 33411 Phone: 561-793-6170 Fax: 561-795-3683 |
Brett Fried, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 11412 Okeechobee Blvd, Royal Palm Beach, FL 33411 Phone: 561-793-6170 Fax: 561-795-3683 |
News Archive
Urgent action needed to avoid preventable strokes in Asia-Pacific region, says new report
Experts from medical and patient communities call on national policymakers in the Asia-Pacific region to take urgent action against preventable strokes that strike millions of people with atrial fibrillation each year.
Indian production of cheap generic drugs could be banned
To ensure India meets World Trade Organisation (WTO) rules on the production of drugs, the Indian Parliament has approved legislation by the parliament's lower house, to ban domestic firms from manufacturing low-cost generic copies of patented drugs.
Discovery Labs receives FDA guidance to gain Surfaxin approval for RDS in premature infants
Discovery Laboratories, Inc. announces today that it has received written guidance from the U.S. Food and Drug Administration (FDA) that is consistent with its ongoing, comprehensive preclinical program to resolve the sole remaining chemistry, manufacturing & control (CMC) issue necessary to potentially gain FDA marketing approval for Surfaxin® (lucinactant) for the prevention of Respiratory Distress Syndrome (RDS) in premature infants.
More marijuana dispensaries associated with more marijuana-related hospitalization rates
People who live in areas of California with a higher density of marijuana dispensaries experience a greater number of hospitalizations involving marijuana abuse and dependence, a University of Pittsburgh Graduate School of Public Health analysis discovered.
Sleep experts advise people to reset sleep habits when they reset clocks
On Sunday morning, the clocks will fall back to mark the official end of daylight savings time. Northwestern Medicine sleep experts warn that the one hour time shift can be disruptive to sleep patterns, but that it also offers an excellent opportunity to evaluate and improve sleep patterns.
› Verified 8 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Optometrists
Speech-Language Pathologists
Podiatrists